Primary malignant melanoma of the esophagus: A retrospective analysis of clinical features management and survival of 76 patients

摘要

BackgroundPrimary malignant melanoma of the esophagus (PMME) is rare. Patients with advanced melanoma of esophageal origin tend to have lower response rates to traditional therapies than those with other melanomas. We report our experience of 12 patients with PMME administered PD‐1 inhibitors.